SCHEMBL4867594

SCHEMBL4867594

Cc1cccc(N)c1O.Cc1cccc(N)c1O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.65
▸ TRPA1 O75762 2/20 0.56
▸ CD44 P16070 1/20 0.56
▸ CYP3A4 P08684 3/20 0.52
▸ TDP1 Q9NUW8 2/20 0.52
▸ TSHR P16473 3/20 0.50
▸ PIK3CA P42336 1/20 0.50
▸ GABRA1 P14867 1/20 0.48
▸ GABRB2 P47870 1/20 0.48
▸ KDM4E B2RXH2 4/20 0.46
▸ HPGD P15428 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ MMP2 P08253 1/20 0.46
▸ LMNA P02545 2/20 0.46
▸ GAA P10253 2/20 0.46
▸ MAPT P10636 1/20 0.46
▸ PKM P14618 1/20 0.45
▸ ATM Q13315 1/20 0.44
▸ ALOX15 P16050 1/20 0.42
▸ NOS3 P29474 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29357959 1.00 — —
SCHEMBL33788 1.00 — —
Hydrochloric Acid SCHEMBL6570703 0.97 ALDH1A1 (0.62) ALDH1A1TRPA1CD44CYP3A4TDP1
Bromide SCHEMBL4899892 0.97 ALDH1A1 (0.62) ALDH1A1TRPA1CD44CYP3A4TDP1
SCHEMBL28445504 0.84 ALDH1A1 (0.46) ALDH1A1TRPA1CD44CYP3A4TDP1
SCHEMBL28446637 0.82 ALDH1A1 (0.45) ALDH1A1TRPA1CD44CYP3A4TDP1
SCHEMBL9195298 0.82 ALOX15 (0.47) ALDH1A1TRPA1CD44CYP3A4TDP1
SCHEMBL1172644 0.80 — —
SCHEMBL64141 0.80 — —
SCHEMBL11575272 0.80 ALDH1A1 (1.00) ALDH1A1TRPA1CD44CYP3A4TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7431742-B2 Hair coloring kits and methods of use thereof THE PROCTER & GAMBLE COMPANY (US) 2008-10-07 — — US disclosed
US-20070251025-A1 Hair coloring kits and methods of use thereof THE PROCTER & GAMBLE COMPANY 2007-11-01 — — US disclosed
EP-1385524-A4 PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS ABBOTT GMBH & CO KG (DE) 2006-02-01 — — EP disclosed
EP-1385524-A1 PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS Abbott GmbH & Co. KG (DE) 2004-02-04 — — EP disclosed
WO-2002080926-A1 PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS ABBOTT GMBH & CO. KG (DE) 2002-10-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070251025-A1 Hair coloring kits and methods of use thereof COXFA4L2, SQOR, GPX4 ALDH1A1 175/4885TRPA1 2860/4885CD44 253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback